2025/05/27
Information for Our Guests:
Interested individuals are invited to contact us using the お問い合わせ / Inquiry on this site.
Title: PMDA’s Future Vision as a Global Leader in Regulatory Science
Date: Tuesday, May 27, 2025
Time: 12:00-14:00
Venue: Tokyo American Club, Brooklyn rooms (B2F)
Speaker: Yasuhiro Fujiwara, MD, PhD, chief executive at the Pharmaceuticals and Medical Devices Agency (PMDA)
Hosting Committee: Healthcare
Meal: Plated lunch
Guest Fee: ¥9,900
Registration/Cancellation Deadline: Thursday, May 22 (12:00)
Event Overview:
Dr. Yasuhiro Fujiwara, chief executive of the Pharmaceutical and Medical Devices Agency (PMDA), joins us for a presentation in which he will share his vision for the future of PDMA. This includes issues faced by innovative global companies entering the Japanese market, how they can connect the Washington, DC, office to the people they serve, the changing future of clinical trials, and the next generation of gene therapy.
The PMDA plays three key roles: providing relief services for people injured by adverse reactions to drugs and biological medical products; conducting product reviews; and recommending safety measures. They are engaged in ensuring the quality, efficacy, and safety of medical products such as drugs, vaccines, biologics, medical devices, and regenerative medical goods. This responsibility ranges from development to post-market stages, and aims to provide citizens and healthcare professionals with rapid access to safer, more effective medical products and to ensure their safe use.
Don’t miss this chance to learn about the trajectory and vision of medical regulation in Japan and the critical trends in this space.
Information source:
http://www.accj.or.jp/accj-events
